AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Recruitingn/aAges 19 Years - 100 YearsAllBon-Kwon Koo
💬

In plain words

What the trial is, and whether it could suit you

This study is a prospective, multicenter, open-label, observational study to investigate the impact of using drug-coated balloons (DCBs) in the treatment of coronary artery lesions in patients with multivessel coronary artery disease (MVD), as opposed to the default strategy of using only drug-eluting stents (DES). The investigators aim to assess changes in clinical practice towards a hybrid treatment strategy (DES and DCB) and its effects on clinical outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 19 or older 2. Multivessel coronary artery disease patients requiring coronary intervention * Stenosis of 2 or more major coronary arteries or major coronary artery branches (Vessel size ≥2.5mm) with diameter stenosis ≥50% or fractional flow reserve ≤0.80 requiring repeat revascularization * Having stenotic lesions requiring revascularization with a vessel size of 2.5mm to 3.0mm 3. Capable of understanding the risks and benefits of participating in the study and providing informed consent Exclusion Criteria: 1. Incapable of voluntarily providing informed consent 2. Allergy or contraindication to aspirin, P2Y12 inhibitors, or components of drug-eluting stents 3. Cardiogenic shock or cardiac arrest patients 4. Patients with severe left ventricular systolic dysfunction (ejection fraction \<30%) 5. Patients for whom coronary artery bypass surgery is prioritized over coronary artery intervention 6. Patients with severe valvular heart disease requiring open heart surgery 7. Pregnant or lactating women
💊

What it tests

  • drug-coated balloon
  • drug-eluting stent
📍

Where

1 site
Bon-Kwon Koo
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy